Xience/Promus for Long Coronary Lesion Registry
- Conditions
- Long Coronary Artery Disease
- Interventions
- Device: Intracoronary stent implantation
- Registration Number
- NCT01147237
- Lead Sponsor
- Society for Advancement of Coronary Intervention Research
- Brief Summary
The utilization of everolimus-eluting coronary stents in a coronary artery diseases is effective in reducing both repeat revascularization and major adverse cardiac events within two year follow-up. To evaluate the procedural, short and long term clinical outcomes of multiple everolimus-eluting coronary stent implantation in long (\>30mm) coronary lesions.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 450
- Age ≥20 years and are able to undergo CABG
- Females who are not pregnant
- Patients who present with angina symptoms or myocardial ischemia
- Patients available for post-procedural observation and coronary angiography at 24 months
- Patients who have signed patient informed consent
- Lesion length is more than 30mm
- De novo lesion or non-stented restenosed lesion
- Patients contraindicated for antiplatelet therapy or anticoagulant therapy
- Patients with significant allergic reaction to contrast medium
- Chronic total occlusion
- Lesion with TIMI0
- Patients with chronic renal failure (SCr>3.0mg/dl) -
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Single arm study Intracoronary stent implantation -
- Primary Outcome Measures
Name Time Method Target lesion revascularization rate 1 year
- Secondary Outcome Measures
Name Time Method Technical success Initial Angiographic restenosis 9 months Target vessel revascularization 2 year Target lesion revascularization 2 year Incidences of acute, sub acute, and late stent thrombosis 2 year Incidence of MACCE 2 year defined as cardiac death, nonfatal acute myocardial infarction and cerebrovascular events
Trial Locations
- Locations (31)
JR Tokyo General Hospital
🇯🇵Shibuya, Tokyo, Japan
Tokyo Medical University Hospital
🇯🇵Shinjuku, Tokyo, Japan
Itabashi Chuo Medical Center
🇯🇵Itabashi, Tokyo, Japan
Ayase Heart Hospital
🇯🇵Adachi, Tokyo, Japan
Juntendo University Hospital
🇯🇵Bunkyo, Tokyo, Japan
Tokyo-kita Social Insurance Hospital
🇯🇵Kita, Tokyo, Japan
Cardiovascular Institute Hospital
🇯🇵Minato-ku, Tokyo, Japan
Hakodate Goryokaku Hospital
🇯🇵Hakodate, Hokkaido, Japan
Kinikyo Chuo Hospital
🇯🇵Sapporo, Hokkaido, Japan
Sapporo Orthopaedic Cardiovascular Hospital
🇯🇵Sapporo, Hokkaido, Japan
Shuwa General Hospital
🇯🇵Kasukabe, Saitama, Japan
Toyohashi Heart Center
🇯🇵Toyohashi, Aichi, Japan
Japanese Red Cross Nagoya Daiichi Hospital
🇯🇵Nagoya, Aichi, Japan
Hoshi General Hospital
🇯🇵Koriyama, Fukushima, Japan
Engaru-Kosei General Hospital
🇯🇵Engaru, Hokkaido, Japan
Gunma Prefectural Cardiovascular Center
🇯🇵Maebashi, Gunma, Japan
Hiraka General Hospital
🇯🇵Yokote, Akita, Japan
Kokura memorial hospital
🇯🇵Kitakyushu, Fukuoka, Japan
Abashiri Kosei General Hospital
🇯🇵Abashiri, Hokkaido, Japan
Obihiro National Hospital
🇯🇵Obihiro, Hokkaido, Japan
Daini Okamoto Hospital
🇯🇵Uji, Kyoto, Japan
Saiseikai Fukuoka General Hospital
🇯🇵Fukuoka, Japan
Shinko Kakogawa Hospital
🇯🇵Kakogawa, Hyogo, Japan
Rinku General Medical Center
🇯🇵Izumiotsu, Osaka, Japan
Miyagi Cardiovascular & Respiratory Center
🇯🇵Kurihara, Miyagi, Japan
Tokyo Metropolitan Police Hospital
🇯🇵Tokyo, Japan
Kasukabe Chuo General Hospital
🇯🇵Kasukabe, Saitama, Japan
Sakurabashi Watanabe Hospital
🇯🇵Osaka, Japan
Higashi Cardiovascular clinic
🇯🇵Toyohashi, Aichi, Japan
Kusatsu Heart Center
🇯🇵Kusatsu, Shiga, Japan
Matsumoto Kyoritsu Hospital
🇯🇵Matsumoto, Nagano, Japan